Rozencweig M, Von Hoff D D, Legha S S, Cysyk R L, Muggia F M
Recent Results Cancer Res. 1980;74:250-7. doi: 10.1007/978-3-642-81488-4_29.
4'-(9-Acridinylamino)methanesulfon-m-anisidide (m-AMSA; NSC-249992) is a new anticancer agent that has undergone extensive experimental investigation. Clinical trials have recently been initiated and current data suggest a wide spectrum of antitumor activity in human cancer.